It is with great excitement that we welcome Fernando Jose Ferrer Gago, David Diller, Binbin Kou and Kenneth McGuinness, Ph.D. to the Perpetual Medicines Team!
Perpetual Medicines
Biotechnology Research
Perpetual Medicines is a fully integrated computational peptide therapeutics company.
About us
About Perpetual Medicines Perpetual Medicines is a fully integrated computational peptide therapeutics company that aims to build the next-generation peptide drug discovery engine. Perpetual Medicines’ platform will combine leading-edge methods in computational physics, including MD simulation, FEP, and quantum chemistry, with next-generation AI technologies to predict numerous peptide properties with supreme accuracy. We couple this “dry” platform with a large-scale synthetic laboratory using state-of-the-art biophysical and chemistry methods for high-throughput peptide synthesis & experimentation. Perpetual Medicines is innovating next-generation peptide drugs in oncology, autoimmune, and metabolic diseases.
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Type
- Privately Held
Employees at Perpetual Medicines
Updates
-
Perpetual Medicines reposted this
Congratulations Perpetual Team ！ https://lnkd.in/gnvMiwHw
-
Let's start a new milestone together！ 😆 https://lnkd.in/gqS9dVDk
Perpetual Raises $8 Million in Seed Financing for AI Discovery of Novel Peptides
chinabiotoday.com
-
Congratulations Perpetual Team ！ https://lnkd.in/gnvMiwHw
Perpetual Medicines raises $8M seed round to apply machine learning in peptide drug discovery
https://endpts.com
-
Revolutionizing Healthcare: Pioneering Peptide Innovations by AI Computational Design 👏🏻[庆祝][https://lnkd.in/eYhfwwd2
Perpetual Medicines Completes $8 Million Seed Round to Advance Integrated Computational Design-Synthesis Platform for Peptide Drug Discovery
businesswire.com
-
Perpetual Medicines reposted this
Perpetual Medicines raised $8,000,000 in their Seed Round-Congrats Kerry Blanchard, Ved Srivastava Full Round Info: https://lnkd.in/gZzdfZzB Round Investors: Chengwei Capital
-
-
Perpetual Medicines reposted this
#Boston-based #perpetualmedicine secures $8M in seed #funding to advance its integrated #computational design and #synthesis platform for peptide drug discovery. The #financing round was led by Chengwei Capital. The company also announced key #appointments to its leadership team, including Kerry L. Blanchard, MD, PhD, Co-founder, Chairman and Chief Executive Officer; Ved Srivastava, PhD, Chief Technology Officer; and Xiang Ye, PhD, Chief Scientific Officer. The funds will be #utilised by the #business to develop its platform for integrated #computational design and synthesis for #peptide drug #development. The objective of computational #peptide therapeutics startup Perpetual #Medicines is to #create a peptide drug discovery engine. To find the peptide chemical space, its platform integrates artificial intelligence (AI) technology and predictive #computational #physics #methodologies with synthetic chemistry. With the goal of #developing the next-generation peptide drug discovery engine, Perpetual Medicines is a fully integrated #computational #peptide #therapeutics enterprise. Perpetual Medicines Chengwei Capital Ved Srivastava Xiang Ye #perpetualmedicines #funding #startup
[Funding alert] Boston-based Perpetual Medicine Secures $8M in Seed Funding
https://startuprise.io